Critical appraisal:Hughes MC, Wright A, Barbour A, Thomas J, Smithers BM, Green AC, et al 2013 2

From Cancer Guidelines Wiki

Risk of bias assessment: cohort study

Subject selection
"New technology" group
Selected group
Comparison group
Selected group
Comparability of groups on demographic characteristics and clinical features
Not comparable but adjusted analysis used
Measurement of outcomes
Outcome measures blind to technology used
No, but objective measures used
Same method of measurement used across comparison groups
Yes
Completeness of follow-up
Was follow-up complete and were all patients included in the analysis?
Yes (follow-up >95%) or survival analysis using all patients
Overall risk of bias
Moderate risk of bias Additional comments: Please replace this text and include any additional comments in regards to your quality rating


Jutta's tick icon.png This appraisal has been completed.


Article
Hughes MC, Wright A, Barbour A, Thomas J, Smithers BM, Green AC, et al. Patients undergoing lymphadenectomy for stage III melanomas of known or unknown primary site do not differ in outcome. Int J Cancer 2013 Dec 15;133(12):3000-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23754707.
Assigned to
User:Lyndal.alchin
Topic area
Guidelines:Melanoma
Clinical question
Form
Form:Quality appraisal cohort


Section below only relevant for Cancer Council Project Officer

Edit appraisal assignment